Bio-Rad Laboratories (BIO) Shares Repurchased (2017 - 2026)

Bio-Rad Laboratories (BIO) has 10 years of Shares Repurchased data on file, last reported at $47.8 million in Q1 2026.

• Quarterly Shares Repurchased fell 53.09% year-over-year to $47.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $241.4 million (down 19.75% YoY) and the FY2025 annual result came in at $295.5 million, up 45.14% from the prior year.
• Shares Repurchased slipped to $47.8 million in Q1 2026 per BIO's latest filing, from $53.4 million in the prior quarter.
• Across five years, Shares Repurchased topped out at $207.4 million in Q2 2023 and bottomed at $4.7 million in Q1 2024.
• The 5-year median for Shares Repurchased is $99.4 million (2024), against an average of $99.3 million.
• The widest annual swing landed in 2025, when Shares Repurchased jumped 2068.09%; it then sank 53.09% in 2026.
• Tracing BIO's Shares Repurchased over 5 years: stood at $90.7 million in 2022, then jumped by 120.48% to $200.0 million in 2023, then sank by 51.04% to $97.9 million in 2024, then slumped by 45.45% to $53.4 million in 2025, then decreased by 10.49% to $47.8 million in 2026.
• Per Business Quant, the three latest BIO Shares Repurchased figures stand at $47.8 million (Q1 2026), $53.4 million (Q3 2025), and $140.2 million (Q2 2025).

Peer Comparison